James B. Wood, MD

Bio

James B. Wood, MD, MSCI, is an Assistant Professor of Pediatrics at the Indiana University School of Medicine in the Ryan White Center for Pediatric Infectious Diseases and Global Health and Pediatric & Adolescent Clinical Effectiveness Research divisions. He completed his medical school training at Georgetown University School of Medicine and Pediatrics residency at Wake Forest Baptist Medical Center. He completed a fellowship in Pediatric Infectious Diseases and a Masters of Science in Clinical Investigation from Vanderbilt University School of Medicine. 

Dr. Wood takes care of patients at Riley Hospital for Children with a variety of infectious diseases, including pneumonia, bone and joint infections, sepsis and infections in immunodeficient patients. 

Dr. Wood's research is focused on the immune response, epidemiology and clinical care of children with Staphylococcus aureus infections, including MRSA. He is interested in improving clinical care of patients with bone and join infections as well as the development and implementation of novel diagnostic, therapeutic and vaccine targets. He is also interested in the pathogenesis and treatment of Kawaski Disease. 

Key Publications

 Wood JB, Jones LS, Soper NR, Creech CB, Thomsen I. Commercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Cytotoxin LukAB. Antimicrob Agents Chemother. 2017; pii:AAC.00968-17 [Epub ahead of print].

Thomsen IP, Sapparapu G, James DB, Cassat JE, Nagarsheth M, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE. Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB (LukAB) isolated following invasive human infection reveal diverse binding and modes of action. J Infect Dis 2017; 215(7):1124-31.

An TJ, Benvenuti M, Mignemi ME, Martus J, Wood JB, Thomsen IP, Schoenecker JG. Similar Clinical Severity and Outcomes for MRSA and MSSA Pediatric Musculoskeletal Infection. Open Forum Infect Dis 2017; 4(1):ofx013.

 Wood JB, Thomsen IP, Creech BC. Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin. J Ped Infect Dis Soc 2016; 5(4):480-2. 

 Wood JB, Johnson DP. Choosing Wisely: Things We Do For No Reason: Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children. J Hosp Med 2016; 11(7):505-8.